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Zebrafish (ZF,Danio rerio) has emerged as an important and popular model species to study
different human diseases. Key regulators of skeletal development and calcium metabolism
are highly conserved between mammals and ZF. The corresponding orthologs share sig-
nificant sequence similarities and an overlap in expression patterns when compared to
mammals, making ZF a potential model for the study of mineralization-related disorders
and soft tissue mineralization. To characterize the function of early mineralization-related
genes in ZF, these genes can be knocked down by injecting morpholinos into early stage
embryos. Validation of the morpholino needs to be performed and the concern of aspecific
effects can be addressed by applying one or more independent techniques to knock down
the gene of interest. Post-injection assessment of early mineralization defects can be done
using general light microscopy, calcein staining, Alizarin red staining, Alizarin red-Alcian
blue double staining, and by the use of transgenic lines. Examination of general molec-
ular defects can be done by performing protein and gene expression analysis, and more
specific processes can be explored by investigating ectopic mineralization-related mecha-
nisms such as apoptosis and mitochondrial dysfunction. In this paper, we will discuss all
details about the aforementioned techniques; shared knowledge will be very useful for the
future investigation of ZF models for ectopic mineralization disorders and to understand
the underlying pathways involved in soft tissue calcification.
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INTRODUCTION
Mineralization is an essential step in the process of skeletal tissue
formation, which needs to be rigorously controlled and restricted
to specific regions. Though incompletely understood,multiple fac-
tors – both agonists and inhibitors – have been shown to work
synergistically in achieving physiological mineralization of bone
and dental tissue (Hosen et al., 2012). In many cases, ectopic
mineralization results from a disturbance of the complex inter-
play between mineralization propagators and antagonists set out
to regulate this process (Shanahan et al., 2011). Although most
soft tissues can undergo calcification, certain ones – including
skin, kidneys, cartilage and tendons, eyes, and vasculature – are
considerably more prone. Pathologic mineralization in any of
these tissues may result in disease with significant morbidity and
mortality (Viegas et al., 2009). The mechanisms contributing to
physiological calcification not only play a pivotal role in the patho-
physiology and clinical manifestations of these diseases, but also
in the prognosis and possible therapeutic options for rare as well
as more common calcification disorders.
Traditionally, mice have been the preferred models of human
diseases, often through the development of Knockout (KO) ani-
mals by targeted ablation of the corresponding genes. While the KO
mice often show remarkable similarity to the human phenotype
both at the genetic, gross morphologic, histopathologic, and ultra-
structural level, this model system knows considerable limitations
(Lieschke and Currie, 2007). It may take several years to develop a
KO mouse and in some cases, development of a KO mouse of the
corresponding human disease is not feasible due to the absence of
the corresponding gene in the mouse genome such as the human
SMAD9 gene (Li et al., 2007). These considerations, together with
cost containment, the large space needed to keep the animals and
low number of progeny, has prompted the search for alternative
model systems to study mineralization-related disorders.
The zebrafish (ZF, Danio rerio), a freshwater vertebrate belong-
ing to the teleosts, has become an important model for the study
of basic pathogenetic mechanisms in different human diseases.
The popularity of the ZF as a model organism is due to some
important properties including their easy maintenance in the
laboratory at low cost, the production of large numbers of syn-
chronous developing embryos per mating, the short reproductive
cycle with external fertilization and rapid rate of development, the
optical transparency of the embryos, and the possibility to con-
duct high resolution in vivo imaging, availability of a wide range
of molecular techniques such as large-scale genome mutagenesis
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and over-expression/knock-down approaches, and freely available
web based resources, i.e., ZFIN, Zebrafish International Resource
Center (ZIRC), Trans-NIH ZF initiative, ZF-Health, etc.
The ZF genomic sequence, which was completely mapped in
2009 (Bhartiya et al., 2010), demonstrates about 70% homology
with the human genome, suggesting the evolutionary conserva-
tion of a large number of genes and genetic pathways. Due to an
ancient genome duplication event that occurred after divergence
of actinopterygian and sarcopterygian ancestors, a substantial
number of ZF genes are present in two or more copies (Woods
et al., 2000; Lu et al., 2012). Although the genome duplication
can complicate gene function analysis, in some cases, this resulted
in the partitioning of ancestral gene functions between dupli-
cated descendants. This role-separation by paralogs can provide
a unique opportunity to study the sub-functions of an individual
human gene (Postlethwait et al., 2004).
To explore physiological and aberrant (soft tissue) mineraliza-
tion in ZF, till now the bone, skin, scales, and vasculature have been
intensively studied. ZF have been proposed as a model to study
osteogenesis, bone metabolism, and remodeling based on study of
their scales, although these structures are strictly speaking tooth-
and not bone-related (Sire and Akimenko, 2004; Pasqualetti et al.,
2012). Bone mineralization is an essential and well-orchestrated
process in vertebrates in which crystals of calcium phosphate are
orderly arranged into hydroxyapatite crystals in very close asso-
ciation with collagen fibers to build the bone mineralized matrix
(Kawasaki et al., 2009). The ZF skeleton shows high similarity
with human bones in terms of cells, matrix proteins, and molecu-
lar signaling pathways involved. The latter include Notch, Wnt,
and TGF beta/bone morphogenetic proteins (BMP) signaling
pathways (Rusanescu et al., 2008).
The skin of ZF consists of two layers: the epidermis and the
dermis. At 1 day post fertilization (dpf), two different layers repre-
senting the epidermis and the dermis can be recognized. At 6 dpf,
a two cell layer epidermis can be observed, clearly separated from
the underlying connective tissue stroma (Li et al., 2011). Despite
several structural differences (lack of keratinization, presence of
several unicellular glands, etc.), the epidermis of the ZF shows
high homology with the human epidermis, and several similar
molecular genetic factors and mechanisms – including the retinol-
binding protein 4 (RBP4) and apolipoprotein Eb (APOEB) – were
reported in both species in the process of (epi)dermal develop-
ment and homeostasis (Tingaud-Sequeira et al., 2006). However,
the underlying molecular mechanisms of scale calcification which
occur during ZF development are still incompletely understood.
The scales of ZF, represent a significant reservoir of calcium and are
subjected to a specific mineralization pattern. In elasmoid scales,
deposition of mineralization-related proteins occurs from the epi-
dermis into the dermis (Sire et al., 1997a,b; Hong et al., 2011).
Besides detailed morphological studies, characterization of the
molecular events involved in scale development has been initiated,
revealing the role of Sonic Hedgehog (Shh), BMP2, 4, osteocalcin,
or osteopontin (Sire and Akimenko, 2004; Hong et al., 2011).
Because of the transparency of the embryonic stages, in vivo
observation of the heart rhythm as well as the vasculature and
circulation in ZF is possible and does not require physical inter-
vention. The heart of ZF embryo starts beating within 26 hour
post fertilization (hpf; Baker et al., 1997) and undergoes looping
by 2 dpf (Stainier et al., 1996). A fully functioning vascular tree is
present by 3 dpf (Sehnert and Stainier, 2002). At 4 dpf, cardiomy-
ocyte proliferation thickens the ventricular wall (Antkiewicz et al.,
2005) and by 5 dpf the heart has developed valves (Forouhar et al.,
2004). To characterize the large number of cardiovascular mutants
in ZF, a comprehensive array of cellular, molecular, physiological,
and genetic techniques has been developed (Warren and Fishman,
1998; Xu et al., 2002). The vital nature of the heart poses a challenge
for studying its function at a molecular level. Although targeted
inactivation of mouse genes can provide a wealth of information,
inactivation of heart-specific genes is frequently hampered by the
early embryonic lethality it creates. By contrast, the ability of ZF
embryos to survive on diffused oxygen for several days without a
functioning cardiovascular system is an important distinguishing
feature. Using ZF, forward genetic screens have been conducted,
identifying more than 100 genes required for heart formation and
function (Chen et al., 1996; Stainier et al., 1996). Studies in ZF,
mice, and humans indicate that Notch works in conjunction with
other angiogenic pathways to pattern and stabilize the vasculature
(Shawber and Kitajewski, 2004). Recent progress in cardiovascu-
lar research has suggested that arterial and valve calcification is the
result of an active process of osteogenic differentiation, induced
by pro-atherogenic inflammatory response. At the molecular level,
the calcification process is regulated by a network of signal-
ing pathways, including Notch, Wnt, and TGFβ/BMP pathways,
which control the master regulator of osteogenesis CBFA1/Runx2
(Rusanescu et al., 2008).
One of the most substantial features of ZF in their use as a
model system to study ectopic mineralization is that the expres-
sion of specific genes can be easily knocked down by injection
of 1–4 cell embryos with morpholino (MO)-based anti-sense
oligonucleotides (Eisen and Smith, 2008). After MO injection
and analysis of its efficacy, a larger number of embryos and
larvae can be comprehensively screened for phenotypic mani-
festations using light microscopy. Once the phenotype has been
characterized, the embryos are readily amenable to further inves-
tigation (Table 1) at the molecular and cellular level, including
calcification-specific stains [i.e., calcein staining, Alizarin Red
(AR-S) Staining, Alcian blue-Alizarin red double staining], the
use of mineralization specific transgenic lines, and analysis of
ectopic calcification-related marker gene expression by quanti-
tative real-time polymerase chain reaction (qPCR) or western
blot analysis, respectively. Also specific pathophysiological mech-
anisms involved in aberrant mineralization, such as apoptosis and
mitochondrial dysfunction can be assessed [e.g., using transferase
dUTP nick end labeling (TUNEL) and MitoTracker staining].
Hitherto, the number of reports applying MO injection to study
(ectopic) mineralization processes and diseases is relatively scarce.
Li et al. (2010) were able to KO about 84% of the abcc6a gene
[a homolog gene of human ABCC6, causing pseudoxanthoma
elasticum (PXE)] and suggested that abcc6a may also have a devel-
opmental role. Hughes et al. (2004) knocked down the otop1
(otopetrin) gene required for the formation of otoliths – large
extracellular biomineral particles involved in transducing sound
into neuronal signals – in the ZF ear, and with more than 96%
of otop1 morphants failing to develop otoliths, demonstrated that
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Table 1 | Overview of different methods that can be applied in zebrafish models for ectopic mineralization.
Methods Application Stages of application in MO approach
MO injection To evaluate the gene function by injecting synthetic anti-sense nucleotide oligomers 1–4 Cell stage embryos
Light microscopic
observation
Phenotypic screening after injection (seeTable 2). Post-injection to morphant death
RNA rescue
experiment
Validation of gene specificity by co-injection of MO and mRNA (encoding protein
from the targeted locus of other species
1–4 Cell stages of embryos
Western blotting Validation of the efficiency of TB MOs After phenotypic confirmation, 1–4 dpf,
until when effect of MO can be observed
PCR Expression profiling of targeted gene From 0- different time points
Validation of the efficiency of SJ MOs After phenotypic confirmation, 1–4 dpf,
until when effect of MO can be observed
Quantitative
real-time PCR
Expression profiling of targeted gene From 0- different time points
Validation of the efficiency of SJ MOs After phenotypic confirmation, 1–4 dpf,
until when effect of MO can be observed
Calcein staining Fluorescent chromophores specifically bind to the calcified skeleton of live ZF
embryos
5 dpf to morphant death
Alizarin red S To identify calcium in tissue sections or whole mount embryos 4 dpf to morphant death
Alcian
blue-Alizarin red
double staining
Alcian blue stains cartilage blue and is used as a counterstaining to AR-S to
distinguish cartilage and bone
4 dpf to morphant death
Alizarin red stains as red in calcified matrix (calcified cartilage, bone)
IHC To detect presence and localization of (mineralization-related) protein in tissue
sections or whole mount embryos
0 hpf to morphant death
µCT imaging Useful for skeletal analysis, used to understand developmental processes of
three-dimensional embryos, embryo phenotyping, and quantitative modeling of
development
5 dpf
ISH To assess gene expression profiling in wild-type embryo and differential gene
expression in morphant
0–4 dpf of embryos, as until 4 dpf effect of
MO can be observed
MS To analyze differential protein expression by measuring the mass-to-charge ratio 0–4 dpf, until MO effect can be observed
2D gel
electrophoresis
To assess differential protein expression, where proteins are separated in the gel
according to their isoelectric point
0–4 dpf, until MO effect can be observed
Microarray Used to identify genome-wide expression of genes. In morphant differential
expression of different gene can be identified
0–4 dpf, until MO effect can be observed
Transcriptome
analysis
More sensitive compared to microarray, used to identify differential expression of
transcripts. By this method closely homologous genes can be distinguished,
alternatively spliced transcripts and non-coding RNAs can be characterized, and rare
transcripts which are undetectable in microarray analysis can be detected
0–4 dpf, until MO effect can be observed
TUNEL staining To assess in situ cell death in the whole mount embryo. TUNEL labels degraded
DNA products enzymatically or by a fluorescent probe and stains apoptotic bodies
30 hpf–4 dpf, until MO effect can be
observed
CMH2DCF
staining
Used to determine oxidative stress or level of ROS in live embryos 0–4 dpf, until MO effect can be observed
MitoTracker Red
CM-H2XRos
Used to determine mitochondrial membrane potentiality in live embryo 0–4 dpf, until MO effect can be observed
Chemical
screening
Used to identify small chemicals which can rescue the morphant phenotype and can
be predicted as a potential drug
0–4 dpf, until MO effect can be observed
MO, morpholino; PCR, polymer chain reaction; IHC, immunohistochemistry; ISH, in situ hybridization; MS, mass spectrophotometry; 2D, 2 dimensional.
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otopetrin 1 has a conserved role in the timing and shaping of
otolith formation. In this paper, we highlight several experimental
procedures which can be used to assess ectopic calcification and
its related processes in ZF, illustrated with current knowledge on
ZF mineralization.
GENE KNOCK-DOWN APPROACHES
Zebrafish has already been proven a good model for forward (phe-
notype driven) genetic approaches, where mutagens are employed
to produce random changes in the DNA followed by phenotypic
evaluation. The unbiased nature has made this approach very pow-
erful (Lieschke and Currie, 2007). Less attention has been given to
reverse (candidate gene-driven) genetic approaches, though these
have become robust tools when forward genetics is less feasible or
to investigate redundant gene function. The ability to make pre-
cise targeted changes to a genome has long been the holy grail
to the reverse genetic approach. ZF genomic sequencing made
it possible to analyze its genes function in a systematic way by
inactivating protein-coding genes by targeted or random muta-
tion (Varshney et al., 2013a). The main obstacles of these reverse
approaches include the need for available knowledge of candi-
date genes and the focus on a single gene or a small group of
genes. Recently Varshney et al. (2013b) performed proviral inser-
tions coupled with high-throughput sequencing and succeeded
to widely mutagenize genes in the ZF genome. To facilitate such
studies, the Zebrafish Insertion Collection (ZInC)1 have gener-
ated a genome-wide KO resource that targets every ZF protein-
coding gene (Varshney et al., 2013a). All mutants from ZInC
are freely available through the ZIRC. The most frequently used
reverse genetic technique is morpholino-induced knock-down.
The specificity of the observed phenotypic effects have always
been a concern using this technology and can be addressed by
running a second or more experiments, applying other reverse
genetic approaches as detailed below.
ANTI-SENSE APPROACHES
Morpholino-induced knock-down
Among many reverse genetic approaches, the most commonly
used method is a gene knock-down approach by injecting so-
called morpholinos (MOs). The ease of use and exciting results
within few hours made this approach increasingly popular for
gene function analysis. MOs are synthetic anti-sense nucleotide
oligomers used to block proper gene expression by binding to
complementary sequences of RNA. Instead of degrading the tar-
get molecules, the knock-down effect is achieved by preventing
cells from making the targeted proteins (Summerton, 1999; Nase-
vicius and Ekker, 2000). Among all gene knock-down reagents,
MOs are the only molecules which have all properties of stabil-
ity, nuclease-resistance, efficacy, comparatively long-term activity,
water solubility, low toxicity, and specificity. MOs consist of stan-
dard nucleic acid bases (Figure 1) but, contrary to nucleic acids,
those bases are bound to morpholine rings and linked through
phosphorodiamidate groups (Summerton and Weller, 1997). To
date, translational blocking (TB) and/or Splice Junction (SJ) MOs
1http://research.nhgri.nih.gov/ZInC/
are commonly used. TB MOs can be used to target sequences
around or slightly upstream from the translation initiation codon,
which interfere with the formation of the ribosomal initiation
complex from the 5′ cap to the start codon (AUG) to prevent
translation of the coding region of the targeted transcript (Draper
et al., 2001). MOs targeted to SJs will modify pre-mRNA splicing
or can block the binding sites of splice-regulatory proteins (Bruno
et al., 2004).
To obtain ZF embryos for MO injection, adult males and
females can be put in breeding tanks and kept separated to control
the laying time, by using a separator in the tank. After the divider
in the breeding tank has been removed, the fish will usually begin
to lay eggs within approximately 30 min, though this period may
be extended. To get the most prominent effect of the MO, injection
should be done in the 1-cell stage (which allows best distribution
of MO in each cell and avoid mosaic phenotypic features). How-
ever, MO injection can be done between the 1- and 8-cell stage
and still give ubiquitous delivery (Nasevicius and Ekker, 2000).
Rapid delivery of MO into embryos is done by MO injections
using a glass micro-needle and a micromanipulator with air pres-
sure. An optimal concentration (<6 ng/nl) of MO is preferred to
obtain the most specific phenotype (Rikin et al., 2010).To over-
come possible redundancy between different paralogs, combined
MO injection targeting the different paralogs can be necessary to
obtain the expected phenotype (Bill et al., 2009; Bedell et al., 2011).
For polygenic disorders, simultaneous injection of different MOs
may allow the inactivation of more than one gene at the same time,
which represents a paramount advantage, compared to any mam-
malian assay available and can be exploited for the identification
of novel gene(s) (Nicoli and Presta, 2007).
Different procedures are available for the maintenance of
injected and wild-type embryos (Lawrence and Mason, 2012). In
our lab, embryos are maintained in an E3 medium (containing
methylene blue) in Petri dishes and kept in an incubator at 28˚C
(Kimmel et al., 1995) until 9 dpf for normal growth. Every day,
half of the E3 medium is replaced by fresh E3 medium and from
6 dpf on the embryos are fed twice a day with 50µM solid dry
granules.
To avoid melanin formation in the skin, which can hide some
internal structures from microscopic observation [phenylthiourea
(PTU), a tyrosinase inhibitor commonly used to block pigmenta-
tion] can be added starting after gastrulation (around 10–12 h) and
before 24 hpf of embryonic life (Renaud et al., 2011). PTU affects
early embryonic development, therefore it is important not to treat
the embryos with PTU before the end of gastrulation (Thisse and
Thisse, 2008).
RNA INTERFERENCE
RNA interference (RNAi) is a powerful approach to knock-down
gene function in different model systems. However, success of
RNAi in ZF is not obvious due to ineffective penetrance or non-
specific effects (Zhao et al., 2008). Simple small-hairpin RNA
(shRNAs)-mediated knock-down approaches also appear inef-
fective in ZF (Wang et al., 2010). Micro-RNAs (miRNAs) are
endogenous∼21–23 nt RNAs which can also regulate gene expres-
sion. Recently, miR-shRNAs were reported to be (12-fold) more
efficient in ZF gene knockdown (De Rienzo et al., 2012). However,
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FIGURE 1 | Binding of the anti-sense morpholino chain to the RNA chain. MOs have standard nucleic acid bases bound to morpholino ring, which are
linked through phosphorodiamidate groups, while RNA has ribose rings which are linked with phosphates.
the capability of germ-line transmission is very poor. Therefore,
the potential of RNAi for stable and conditional gene knock-down
in ZF remains uncertain.
ENGINEERED NUCLEASES
Transcription activator-like effector nucleases
Transcription activator-like effector nucleases (TALENs) are a
powerful and robust approach for efficient inactivation of a tar-
geted gene. TALENs are artificial restriction enzymes generated
by fusing a TAL effector (derived from plant pathogenic bacteria
Xanthomonas) DNA-binding domain to a DNA-cleavage domain
or FokI nuclease. These restriction enzymes are introduced into
cells to edit the genome in situ. When fused to the FokI nuclease
domain, TAL effectors recognize specific DNA sequences using
a straightforward DNA base recognition code. FokI cleaves only
when present as a dimer and the binding of two TAL effectors to
DNA, which allows FokI to dimerize, will thus create a break in the
nucleic acid strand. Because of the specificity of this DNA-binding,
TAL effectors can bind virtually any DNA sequence (Cermak et al.,
2011). TAL effectors possess several advantages, including ease of
design and easier optimization, shows few off-target effects and are
thus potentially more reliable compared to other reverse genetic
approaches (Clark et al., 2011).
Zinc finger nucleases
Another nuclease-based technology for efficient inactivation of a
targeted gene in ZF (Sander et al., 2010, 2011) is the use of zinc
finger nucleases (ZFNs). These are artificial restriction enzymes
generated by fusing engineered zinc finger DNA-binding domain
to a DNA-cleavage domain, and function as dimmers to introduce
targeted DNA double-strand breaks. ZFN treated ZF can transmit
mutant alleles (as if they were heterozygous carriers) and cause
minimal collateral damage to the genomes of treated ZF. More-
over, it is possible to also generate targeted knock-ins in ZF using
ZFNs. However, injected nucleases can be toxic to the embryo
(Doyon et al., 2008; Meng et al., 2008) and together with the gaps
in our understanding of sequence-specific DNA recognition by
zinc fingers can still restrict the ability to construct ZFNs targeting
any desired site in a genome (Lawson and Wolfe, 2011).
TARGETING INDUCED LOCAL LESIONS IN GENOMES
Targeting induced local lesions in genomes (TILLING) is a quick,
reliable, and increasingly popular method to identify chemically
induced point mutations in ZF (Wienholds et al., 2003). The TILL-
ING method combines mutagenesis (by a chemical mutagen) with
a sensitive DNA screening-technique that identifies single base
mutations in a target gene. The TILLING method relies on the for-
mation of DNA heteroduplexes between the wild type and mutant
PCR fragment, formed when multiple alleles are amplified by PCR
and are then heated and cooled. These heteroduplexes are then
incubated with celery derived CelI endonuclease, which recog-
nizes and cleaves mismatches in the heteroduplex DNA generated
by small nuclear polymorphisms (SNPs) and point mutations
(Oleykowski et al., 1998). Labeled digested fragments are sepa-
rated and visualized on slab gel sequencers. Fragments generated
due to the presence of SNPs will be present in all animals. This
approach holds great promise for the rapid identification of large
numbers of mutant alleles from mutagenized libraries. However,
the need for screening large number of F1 fish to find a lesion in a
gene of interest (Wienholds et al., 2002), the requirement of spe-
cialized equipment, and a significant investment in computational
resources and personnel represent the initial bottleneck of this
approach. To date, the “Welcome Trust Sanger Institute” has suc-
cessfully provided 8402 genes (including abcc6) with mutations
under the “Zebrafish Mutation Project (ZMP) KOs for disease
model” by using the TILLING approach2.
2http://www.sanger.ac.uk/Projects/D_rerio/zfm_DAS_conf.shtml
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RETROVIRAL AND TRANSPOSON MEDIATED MUTAGENESIS
Insertional mutagens retrovirus or transposon can be utilized to
identify modified alleles of a target gene. The main advantage of
these systems is readily identifiable tag that simplifies screening
for carriers of a particular disrupted allele within the library (Jao
et al., 2008). It is also possible to generate conditional alleles in
ZF by including recombination sites flanking these gene-breaking
elements (Petzold et al., 2009). A limitation of these insertion
mutagenesis techniques is the inability to generate full null alleles
in most instances.
DOMINANT NEGATIVE APPROACH
Here, a mutant gene product is used to adversely affect the wild-
type gene product within the same cell to get a reduced level of
gene activation. Two main Dominant negative (DN) approaches
are: (1) mutation in a transcription factor that removes the activa-
tion domain, which can block the wild-type transcription factor to
bind with the DNA-binding site, resulting in a reduction of gene
activation, and (2) overexpression of a constitutively active protein
(CAP) with mutation in/manipulation of the regulatory domain,
leading to diminished opportunity for the regulatory subunit of
the wild-type protein to bind with its receptor, and binding of a
malfunctioning protein domain to the receptor will decrease the
wild-type protein expression (Concordet et al., 1996). For exam-
ple, in a protein which is functional as a dimer, a mutation leading
to removal of the functional domain while retaining the dimer-
ized domain would cause a DN phenotype. Lanham et al. (2011)
successfully used aryl hydrocarbon receptor 2 (Ahr2) as a DN
approach in ZF to protect developing ZF from dioxin toxicity
by removing the C-terminal transactivation domain or replac-
ing it with an inhibitory domain. CAP also been used to explore
the function of various components of signal transduction path-
ways. The main advantage of DN approach over anti-sense RNA
strategies is the possibility of producing null mutations. The disad-
vantages of DN approaches are that the technique is not applicable
to all genes, has a relatively low throughput, and that it is usually
impossible to fully understand the true endogenous function of
the molecule in vivo (Niwa and Slack, 2007).
PHARMACOLOGICAL APPROACHES
Pharmacological approaches (PA) are not true reverse genetic
approaches, because they do not depend on specific knowledge
of an individual gene of an organism. Once the treatment with
a reagent reveals phenotypic consequences, this can be utilized
to understand interacting molecular pathways. Many pharmaco-
logical reagents are used in the ZF model system including, e.g.,
cyclopamine – an inhibitor of Shh signaling pathway – (Cooper
et al., 1998) or SU5614 and SU1498-an inhibitor of VEGF/Flk-1
tyrosine kinase signaling (Liang et al., 2001). Biochemical charac-
terization of the pharmacological reagents is highly recommended
before applying them in the model system. Exert pleiotropic effects
is the bottleneck of using pharmacological reagents which can
result an unspecific phenotype (Skromne and Prince, 2008).
INDUCIBLE SYSTEMS
Most of the aforementioned techniques used in the ZF gene-
knock-down process are only suitable to evaluate phenotype and
gene function in early embryonic stages, as severe malfunction of
embryo leads to early death. So, gene function(s) at late stages
are missed, which can be overcome by inducible systems (IS)
including heat shock promoters orgal4-UAS system. Application
of IS can be done by regulating the activity of the protein or
regulating the expression of the corresponding gene. In ZF, down-
stream gene expression can be induced throughout the body
by raising the temperature from 28.5 to 38˚C (Shoji and Sato-
Maeda, 2008). Heat shock protein (hsp) promoters have been
used to regulate exogenous gene expression in a variety of studies.
The hsp promoter can be used to search cis-acting transcrip-
tional elements during ZF embryogenesis. Hsp:egfp (enhanced
green fluorescence protein) can be injected into fertilized eggs
with distal DNA fragments for tissue/cell type specific activa-
tion (Islam et al., 2006). One such way for inducing heat shock
response in targeted cell is by using a laser microbeam under the
microscope. The main advantage of this technique is visualiza-
tion of a whole cell due to stable and longtime expression of
the GFP protein, however laser ablation can be sensitive to the
cells.
POST-INJECTION FOLLOW-UP
EVALUATION OF THE PHENOTYPE
Phenotypic screening is mainly done based on classic criteria
(Haffter et al., 1996), which can provide important information
on gene function as well as the molecular events that underlie a
biological process. Such screening focuses primarily on morpho-
logical landmarks by dissecting microscopy. A significant number
of phenotypic traits can be screened for, as summarized in Table 2.
The phenotypic screening is conducted at different time points
corresponding to the embryonic developmental stages (Figure 2).
Due to transient character of MO-induced gene knockdown, with
efficient knockdown up to 4–5 dpf, phenotypic screening is prefer-
ably done during this time frame (Nasevicius and Ekker, 2000; Bill
et al., 2009).
Morpholino mediated knockdown to study gene function in
ZF offers many advantages, including ease of delivery, a high effi-
cacy, and rapid phenotypic screening. However, because of their
dilution in rapidly growing embryos, the effect of MOs is tempo-
rary, preventing gene function analysis during the entire life cycle
of ZF. Moreover, many genes – e.g., the macrophage stimulating
protein Msp (recently found to have a role in the regulation of
calcium homeostasis of adult ZF) (Huitema et al., 2012) – which
are expressed during the adult period and some organs such as
the skeleton which have only fully matured after 2–3 weeks can-
not be studied sufficiently after MO knockdown. Altogether, this
emphasizes the usefulness of permanent mutants in addition to
MO-induced models.
MORPHANT VALIDATION
Every MO-induced phenotype must be validated to confirm that
it is due to gene-specific effects. Besides the application of an
independent knock-down approach as described above, several
MO-specific validation steps need to be addressed. First, to assess
the phenotypic variation and effect of the injection procedure,
commercially available standard control MO needs to be injected
in parallel with the active MO. Secondly, for each targeted gene, the
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Table 2 | Phenotypic traits which can be screened in ZF embryos
beyond early development.
System Phenotypic trait
Body axis Dorsilisation (48 hpf)
Ventrilisation (48 hpf)
Prechordal plate and hatching (24 hpf)
Tail (24–48 hpf)
Mesoderm Notochord formation, differentiation, and degeneration
(24 hpf)
Somite formation and patterning (24 hpf)
Central
nervous
system
Forebrain (24 hpf)
Midbrain (24 hpf)
Hindbrain (24 hpf)
Neural tube – spinal cord (24 hpf)
Organs Vasculature (e.g., aortic arches, dorsal aorta,
common/posterior cardinal vein, blood island; 24–48 hpf)
Heart: morphology, beating (48 hpf)
Liver, kidney, gut (larva stadium)
Eye (24 hpf)
Ear (48 hpf)
Otoliths (48 hpf)
Pigmentation Cell number and pattern (48 hpf)
Melanin pigmentation (48 hpf)
Motility Muscles (48 hpf)
Pectoral and caudal fin (48 hpf – larva stadium)
Reduced motility (48 hpf)
For each trait, the timing when evaluation can start is mentioned. From this timing
on, serial evaluations in time are usually performed.
injection of both TB and SJ MO is recommended, to reveal the role
of either the entire protein-coding region of the gene, or of certain
exons. MOs appear to have non-target-related phenotypes includ-
ing overall developmental delay and cell death due to activation
of p53-mediated apoptosis (Ekker and Larson, 2001), which can
be overcome by using stage matched (rather than age matched)
control embryos and co-injection of an anti-p53 MO along with
the experimental MO. Injection of SJ MO generally causes skip-
ping of the targeted exon or retention of the adjacent intron while
TB MO blocks gene transcription. These molecular effects can be
validated by conducting western blotting in case of SJ MO’s and
RT-PCR for TB MO’s. Further evidence of the specificity of the
gene knockdown can be obtained by rescuing the phenotype by
mRNA injection.
RNA rescue experiments
mRNA rescue is the most reliable approach to examine the speci-
ficity of the effects of MO knockdown. To rescue the gene-specific
phenotype, co-injection of the MO of interest and synthetic
mRNA encoding the targeted protein can be done at the 1–4 cell
stage of the embryo (Hyatt and Ekker, 1999; Bedell et al., 2011).
many genes, knockdown by MOs followed by ubiquitous mRNA
delivery rarely results in truly rescued phenotypes (Bedell et al.,
FIGURE 2 | Developmental stages of zebrafish, from zygote to adult.
Zygote: the newly formed fertilized egg after completion of the first zygotic
cell cycle. Cleavage: zygotic cell cycles 2–7 occur rapidly and synchronously.
Blastula: rapid and metasynchronous cell cycles (8, 9) occur, which give way
to lengthened, asynchronous ones at the midblastula transition, then
epiboly begins. Epiboly is the first coordinated cell movement in zebrafish
embryos and begins before gastrulation. Gastrula: morphogenetic
movements of involution, convergence, and extension from the epiblast,
hypoblast, and embryonic axis through the end of epiboly occur. Bud-100%
epiboly is the stage where epiboly completely covers the yolk plug.
Segmentation: Somites (after completion of epiboly and initial appearance
of the tail bud, first the somatic furrow forms and makes a boundary,
between what will become the first and second somites), pharyngeal arch
primordia, and neuromeres develop, primary organogenesis and earliest
movements take place, and the tail appears. Pharyngula: phylotypic stage
of embryo, body axis straightens from its early curvature around the yolk
sac; circulation, pigmentation, and fins begin development. Hatching:
completion of rapid morphogenesis of primary organ systems, cartilage
development in head and pectoral fin, hatching occurs asynchronously
across individuals. Larval: swim bladder inflates; food-seeking and active
avoidance behaviors.
2011).The most important issues to consider in RNA rescue exper-
iments are: (1) achievement of appropriate levels of injected MO
and mRNA by co-injecting different concentrations of both com-
ponents (Little and Mullins, 2004), (2) making sure that injected
synthetic mRNA does not include the MO target sequence (Eisen
and Smith, 2008). For TB MOs against the 5′ UTR sequence,
the open reading frame can be cloned by PCR into a standard
transcription vector (Hyatt and Ekker, 1999). For MOs that tar-
get part of the open reading frame, the rescue constructs can
be engineered to change the nucleotide sequence without alter-
ing the encoded protein through degradation of the genetic code
(Bill et al., 2009). Another frequently used approach for rescuing
TB morphant is co-injection of mRNA from a different species.
In their ZF model for PXE, Li et al. (2010) injected full-length
mouse mRNA together with the MO; this co-injection com-
pletely reversed the phenotypic effects of the MO and the rescued
embryos showed essentially the same morphology as controls. Co-
injection of SJ MO and full-length mRNA (whose sequence is
non-homologous to the SJ MO) can rescue a SJ morphant (Cline
et al., 2012).
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Qualitative and quantitative validation methods
The effect of TB MOs can be validated by western blotting, which
correlates reduced protein levels of the targeted gene with an
observed phenotype (Hutchinson and Eisen, 2006). The main
obstacle for performing western blot in ZF is the currently
limited availability of antibodies that are specifically generated
to recognize ZF proteins, although a number of already avail-
able antibodies from other origins show cross-reactivity with ZF
proteins.
When using SJ MO, the phenotype can be validated with PCR.
Qualitative evaluation of exon skipping or intron retention can
be done by performing RT-PCR with primers located in exons
upstream and downstream of the MO-targeted sequence showing
smaller and larger band respectively in addition to the original
band (Figure 3). Intron retention or exon skipping can result
in a frameshift and consequently nonsense-mediated decay and
reduced transcript levels can be assessed quantitatively by using
quantitative real-time PCR (qRT-PCR).
CHARACTERIZATION OF (ECTOPIC) MINERALIZATION
PHENOTYPES
CALCEIN STAINING
Calcein (C30H26N2O13) is a fluorescent chromophore that specif-
ically binds to calcium. As the skeletal system contains calcified
structures, calcein has been used to label bone structures and to
study bone growth (Ducy et al., 2000). During calcein staining,
fluorescent chromophores of calcein rapidly penetrate into ZF
embryos and specifically bind to the calcified skeleton (Figure 4).
Calcein staining can be used to follow the development of skeletal
structures in ZF embryos. Calcified skeletal structures appear in a
progressive fashion from head to tail. First appearance of calcein
signals, observed at ∼5 dpf are restricted to the head, followed by
the axial skeleton in the trunk (Du et al., 2001). Du et al. (2001)
observed that the axial skeleton calcified in two domains. This was
later confirmed by AR-S staining (Bensimon-Brito et al., 2012).
The first domain consists of three anterior vertebral centra (cen-
tra 3–5), whereas the second domain consists of the remaining
abdominal and caudal centra which develop in an anterior-to-
posterior direction. This confirms the sensitivity of calcein staining
for visualizing mineralized structures in developing ZF embryos
and its effectiveness for detecting defective bone structures and
mineralization.
ALIZARIN RED S STAINING
Alizarin Red S is an anthraquinone derivative used to identify cal-
cium in tissue sections or whole mount embryos, where tissue
calcium forms an AR-S-calcium complex in a chelation process,
producing a birefringent end product (Nejati-Yazdinejad, 2006).
The reaction is not strictly specific for calcium, since magnesium,
manganese, barium, strontium, and iron may interfere, but these
elements usually do not occur in sufficient concentration to inter-
fere with the staining (Lievremont et al., 1982). AR-S staining
can be performed on both live embryos and adult ZF as well as
on fixed tissues. In live embryos, AR-S is used as a vital stain
which labels mineralized matrix and is a very sensitive method
for detecting bones (Kimmel et al., 1995; Walker and Kimmel,
2007). On the other hand, in fixed embryos or adult fish, the fix-
ation itself is a very critical step for good AR-S staining. As PFA
negatively affects bone staining, fixation with 4% PFA should be
restricted to 2 h (Figure 5; Huitema et al., 2012) demonstrated an
ectopic mineralization phenotype in dragon fish (dgf) mutants
by Alizarin red staining, which exhibit ectopic mineralization in
the craniofacial and axial skeleton and encode a loss-of func-
tion allele of ectonucleotide pyrophosphatase phosphodiesterase
1 (enpp1).
Besides AR-S staining, an Alcian Blue-AR-S double staining
can be used to distinguish cartilage and bone. Walker and Kim-
mel (2007) developed an acid-free alcian blue-AR-S staining
method which is now widely used to stain cartilage and bone
simultaneously in ZF larvae.
FIGURE 3 | Evaluation of the effect of SJ MO in the PCR product.
Hypothetical representation of intron retention and exon skipping as a
consequence of SJ MO injection. (A) MO is placed on exon2/intron2
border on targated genes pre-mRNA. The result can show (B) retention of
intron 2, or (C) skipping of exon 2. FW, forward primer; REV, reverse
primer.
Frontiers in Genetics | Systems Biology May 2013 | Volume 4 | Article 74 | 8
Hosen et al. Zebrafish models for ectopic mineralization disorders
FIGURE 4 | Calcein staining of 6 dpf embryos showing staining of the
ceratobranchials 5 (cb5), cleithrum (cl), dentary (d), entopterygoid (en),
opercular bone (op), and parasphenoid (ps), in the skull, and anterior
tip of the notochord (no).
µCT IMAGING
Micro computerized tomography (µCT) is a powerful and prac-
tical tool for the skeletal analysis of diverse model organisms
including ZF. It is used to understand developmental processes
of three-dimensional embryos, embryo phenotyping, and quanti-
tative modeling of development (Figure 6) (Metscher, 2009). The
method is analogous to that used for the 3D imaging of human
structures, on a smaller scale. It is dependent upon the interaction
of large atoms with X-ray beams and requires the use of con-
trast agents, still in development, for imaging anything other than
bone. But the usefulness of µCT imaging for developmental biol-
ogy has been limited by the low inherent contrast of embryonic
tissues. Though it can be envisaged that µCT may also be useful
to demonstrate ectopic calcification in, e.g., soft tissues, its lim-
ited sensitivity in embryos makes it a more useful technique in
adult fish and hence the characterization of mutants instead of
morphants. The ZF is the only well-developed vertebrate genetic
model that is small enough to image the whole animal at cell
resolutions using µCT (Cheng et al., 2011).
MOLECULAR CHARACTERIZATION
IMMUNOHISTOCHEMISTRY
Immunohistochemistry (IHC) is a powerful and commonly used
technique in ZF for determining both the presence and localization
of antigens (e.g., endogenous protein) in cells of a tissue section,
or whole mount embryos and larvae. Sample preparation, espe-
cially sectioning and fixation of tissue, is very critical to maintain
cell morphology, tissue architecture and the antigenicity of tar-
get epitopes. Non-specific binding can cause high background
staining which may mask the detection of the target antigen. It
is also possible to label both whole mount specimens and sections
with two different antibodies, known as the double-labeling tech-
nique. Double-labeling works particularly well with fluorescent
conjugated secondary antibodies and these can be applied at the
same time.
FIGURE 5 | Alizarin Red staining of a 5 dpf embryo showing cleithrum
(cl), opercular bone (op), parasphenoid (ps), and ceratobranchials 5
(cb) with a set of three teeth.
FIGURE 6 | MicroCT scanning of whole 4 dpf embryos. The white spot in
the head region represents a signal for the mineralized otoliths.
Immunohistochemical approaches to reveal the localization of
some calcification-related proteins demonstrated tissue distribu-
tion and accumulation of Bgp and Matrix γ-carboxyglutamic acid
(Gla) protein (Mgp) during the larval stage and in adult tissues of
ZF by IHC shows that Bgp and Mgp proteins were located in all
mineralized tissues during and after calcification including bone
and calcified cartilage of branchial arches (Gavaia et al., 2006).
Being a powerful method to identify specific proteins by using an
antibody, the main obstacle is the availability of antibodies and the
limited cross-reactivity of ZF protein with antibodies originating
from other sources.
WHOLE MOUNT RNA IN SITU HYBRIDIZATION
Whole mount RNA in situ hybridization (ISH) is one of the oldest
and most frequently used techniques used in the ZF research to
investigate the site of expression of a particular gene in an intact
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embryo (Jowett and Lettice, 1994). ISH allows specific nucleic
acid sequences to be detected in morphologically preserved cells
or embryos and is also used to identify novel genes involved in
the same signaling pathways (Thisse and Thisse, 2008). Whole
mount mRNA ISH can also be done to observe MO mediated
gene expression changes. In this case, cDNA of a gene of interest is
used as a template for the synthesis of an anti-sense mRNA probe,
which is used to recognize and bind to the endogenous transcript
through a color or fluorescence-based assay (Thisse and Thisse,
2008). Finally, the expression of the gene can be observed under a
light or fluorescent microscope.
The major advantage for using the ISH technique in ZF com-
pared to other animal models is that, because of its transparency
and small size, the expression of a particular gene can be observed
in the entire embryo. Though whole mount ISH is a quick and
efficient method, the most significant caveat in ZF is the poor
penetration of the RNA probes after 2 days of development; only
superficial tissues (i.e., epithelial cells) are accessible to the probe
at these later developmental stages (Thisse and Thisse, 2008). To
overcome this, embryos can be treated with proteinase K with
optimal concentration, incubation time and temperature for the
embryonic stage to facilitate infiltration of the probes into the
tissue.
ISH was performed to study the expression of the abcc6 gene
(respectively the abcc6a and abcc6b isoform) during ZF devel-
opment. While abcc6a was found to be expressed in Kupffer’s
vesicle, abcc6b expression was evident in the proximal tubules
of the embryonic kidney (Li et al., 2010).
In general, ISH is a laborious technique, taking about 3 days to
complete the whole protocol. Additionally, it is difficult to handle
small embryos because of their fragility throughout the protocol.
So, semi-high-throughput procedures can alternatively be used
to facilitate these experiments by using multiwell plates (instead
of using single tube) and robotics (e.g., IntavisS AG) (Thisse and
Thisse,2008; Bouzaffour et al., 2009). To detect the differential pro-
tein expression in morphant compared to control, ISH followed
by image mapping software can be a useful tool. Alternatively,
post-ISH embedding in plastic, followed by sectioning, yields high
resolution images that allow detailed cellular localization of the
transcripts (Verstraeten et al., 2012).
ASSESSMENT OF GENE EXPRESSION USING QUANTITATIVE
REAL-TIME PCR AND MICROARRAYS
Real-time polymerase chain reaction, also called qPCR, is a labora-
tory technique based on PCR, which is used to detect and measure
minute amounts of nucleic acids in a wide range of samples. The
quantity can be either an absolute number of copies or a relative
amount. The expression pattern of mineralization-related genes
in morphants (i.e., osteocalcin, alkaline phosphatase, bone sialo-
protein) can be assessed by performing quantitative RT-PCR. To
reliably conduct qRT-PCR experiments it is highly recommended
to follow the MIQE guidelines (Bustin et al., 2009). MIQE is a set
of guidelines that describe the minimum information necessary
for evaluating qPCR experiments. Among the requirements is the
need to include at least three biological replicates (e.g., three inde-
pendently injected clutches of embryos) to address the statistical
significance of differences in qPCR results between morphants
and controls. Furthermore, at least two reference genes should be
included as internal controls for normalizing cellular mRNA data.
Reference genes should be stably expressed, and their abundances
should show strong correlation with the total amount of mRNA
present in the samples. In ZF embryos tuba1, bactin1, and elfα are
three stable reference genes which can be used for qPCR experi-
ments comparing morphants and controls (McCurley and Callard,
2008).
Microarray technology can be used to monitor transcriptome
wide expression of genes in ZF embryos. Microarray analysis has
been employed to study the temporal activity of developmentally
regulated genes during ZF embryogenesis (Mathavan et al., 2005)
but also in numerous studies where gene expression was com-
pared between morphants and controls (Jenny et al., 2012; Wei
et al., 2012).
The principle of Next Generation Sequencing (NGS) has
recently been applied to transcriptome profiling (Wang et al.,
2009), which offers several advantages compared to microarrays
or quantitative RT-PCR. Most importantly, RNA-Seq transcrip-
tome profiling can be used to identify rare transcripts which are
undetectable with microarrays. Moreover, RNA-Seq allows more
precise quantification of different transcripts (Wetterbom et al.,
2010).
PROTEOMICS
Physiological mineralization is governed by highly coordinated
changes in the expression of a large number of proteins. Under-
standing these changes at the molecular level can provide impor-
tant insights into physiological and disease mechanisms (Lucitt
et al., 2008). To elucidate these regulatory genetic networks in
a ZF disease model, quantitation of protein expression during
growth and development is essential. In morphants, proteomics
can be used to identify proteins that are differentially expressed
compared to controls. It has been proposed that proteomic stud-
ies should complement genome-wide expression profiling (Love
et al., 2004).
Many approaches can be used for quantitative protein stud-
ies including two dimensional poly acrylamide gel electrophoresis
(2D PAGE), mass spectrometry (MS), liquid chromatography (LC)
and western blotting. Proteomic approaches are however incre-
mentally challenging in ZF because of unavailability of specific
antibodies and the high abundance of yolk proteins in embryos
(Akhtar et al., 2009; Lobner et al., 2012). Further, many protein
identifications have low reproducibility if the sensitivity of detec-
tion is not carefully balanced against rates of false identification
error (Lucitt et al., 2008). Therefore, rigorous statistical analysis is
needed to obtain high quality profiles of proteins.
In the early embryo, the cells forming the embryo consti-
tute only a minor volume compared to the large yolk sac. The
major yolk protein is vitellogenin, a phospholipo-glycoprotein,
which functions as a nutritional source for the development of
the embryo (Denslow et al., 1999). Link et al. (2006) developed
an effective protocol for protein analysis from deyolked embryos.
By pipetting with a narrow tip, the yolk sac can be disrupted. A
buffer of low osmolarity facilitates dissolving of the yolk. The dey-
olking efficiency can be further increased by two additional wash
steps. By removing the yolk, recovery of cellular proteins remained
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high with only a minor reduction of housekeeping gene (mek and
tubulin) observed.
Mass spectrometry
Mass spectrometry is an important method used to character-
ize proteins by measuring the mass-to-charge ratio. The first
step in MS is the ionization of proteins, for which two common
methods can be used: electrospray ionization (ESI) and matrix-
assisted laser desorption/ionization (MALDI). Mass analysis of
proteins can be conducted using either time-of-flight (TOF) MS
or Fourier transform ion cyclotron resonance (FT-ICR). Gener-
ally, a protein sample is a complex mixture of different proteins.
The concentration of a protein can vary between samples and
an overwhelming number of peptides can make it difficult to
interpret the results. To overcome this problem, two methods,
2D gel electrophoresis and high performance liquid chromatog-
raphy, can be used to fractionate the proteins or their peptide
products after enzymatic digestion. In MS, two ways are mainly
used to identify proteins, i.e., Peptide mass fingerprinting and Tan-
dem MS. Observed fragment masses are matched with a database
of predicted masses for given peptide sequences. Several meth-
ods also allow quantitation of proteins by MS, i.e., stable isotope
labeling by amino acids in cell culture (SILAC), isotope coded
affinity tagging (ICAT), iRRAC (isobaric tags for relative and
absolute quantitation), or semi-quantitative MALDI analysis (in
liner mode).
2D gel electrophoresis
After removal of the predominant yolk proteins, high resolution
2D gels in the acidic (pH 4–7) as well as in the basic range (pH 6–9)
can be run, and proteins will be separated according to isoelectric
point. Two biological replicates of each sample have to labeled with
fluorophores (Cy3/Cy5), and an internal control from each sample
labeled with different fluorophores (Cy2) can be used to normal-
ize label differences. DIGE gels are then stained and imaged using
emission wavelengths of the fluorophores. Link et al. (2006) estab-
lished a protocol that is compatible with three color fluorescent
labeling using the Ettan DIGE system, which significantly reduces
inter-gel variability compared to one color stains with a detection
limit less than 1 ng protein. Analysis of 2D gels also allowed to
resolve protein isoforms. Finally, validation of protein expression
changes can be confirmed by western blotting and real-time PCR
studies.
Western blotting
Western blot is a widely accepted analytical technique used to
detect specific proteins in a given sample of tissue homogenate
or extract. The success of western blotting depends on the affin-
ity and specificity of the antibodies and on the abundance of the
target protein. If the yolk sac is not removed only 1 or 2 embryos
(50–100µg) can be loaded per lane on a gel to avoid overloading
effects (Link et al., 2006). As previously stated, antibodies vali-
dated for ZF proteins are not always available which can hamper
the use of this technique. Along with confirmation of TB MO
efficiency, western blotting can also be used to detect differen-
tial expression of a targeted protein in morphant compared to
control.
DISEASE SPECIFIC MECHANISMS
IDENTIFICATION OF PROGRAMED CELL DEATH (APOPTOSIS)
Apoptosis is a form of cell death in which a programed sequence
of events leads to the elimination of cells without inflammation.
Apoptosis plays a pathophysiological role in many mineralization-
related disorders including calcific aortic valve disease (Côté et al.,
2012), osteoarthritis (Sun et al., 2012), and PXE (Mungrue et al.,
2011).
Several methods have been developed for visualizing apop-
totic cells in vitro or in fixed tissues, but few tools are available
for visualizing apoptotic cells in live animals. Methods exist for
labeling apoptotic cells with fluorescent nucleic acid binding dyes,
such as acridine orange, ethidium bromide, and propidium iodide
(Lecoeur et al., 2002). A standardized technique to detect apop-
totic cells in fixed tissue or fixed cells is terminal deoxynucleotidyl
TUNEL, which is based on end labeling of DNA degradation prod-
ucts enzymatically or by a fluorescent probe (Figure 7) (Gavrieli
et al., 1992). Another well-established method to detect apoptotic
cells in vitro is based on loss-of membrane asymmetry during
apoptosis (Fadok et al., 1992). During apoptosis, the normal asym-
metric distribution of phospholipids in the cell membrane is lost,
and phosphatidylserine (PS) is exposed on the outer leaflet of
the lipid bilayer. The calcium-dependent protein Annexin V (A5)
binds PS with high affinity and fluorescently labeled A5 probes
have been widely used to detect apoptotic cells in vitro (Van
Genderen et al., 2006).
Van Ham et al. (2010) recently introduced a new transgenic
fluorescent marker allowing in vivo imaging of apoptotic cells to
understand their dynamics. They fused secreted A5 (secA5) pro-
tein to yellow fluorescent protein (YFP) (secA5-YFP) and showed
that this fusion product specifically labels apoptotic cells in living
ZF; the fluorescent probe can characterize patterns of apoptosis
in living ZF larvae and visualize cell death at single-cell resolu-
tion in vivo. Labeled cells exhibit several other characteristics of
apoptotic cells, and the pattern of apoptotic cells observed by live
imaging was similar to previous findings using TUNEL.
DETECTION OF OXIDATIVE STRESS
Oxidative stress is an imbalance between the systemic manifes-
tations of reactive oxygen species (ROS) and a biological system’s
ability to readily detoxify the reactive intermediates or to repair the
resulting damage. Disturbances in the normal redox state of cells
can cause toxic effects through the production of peroxides and
free radicals that damage all components of the cell, including pro-
teins, lipids, and DNA. Oxidative stress is increasingly implicated
as a possible pathogenic mechanism underlying a wide range of
diseases including mineralization-related disorders such as athero-
sclerosis, cardiovascular disease, or diabetes (Stephens et al., 2009).
Oxidative stress in fibroblasts (Pasquali-Ronchetti et al., 2006),
and elevated oxidative stress markers in the circulation (Garcia-
Fernandez et al., 2008) of patients with PXE reveal its possible role
in the pathogenesis of this ectopic calcification disease.
To determine the level of ROS, fluorescent reporter molecules
CMH2DCF and Dihydrorhodamine can be administered, both
of which have been successfully applied to live embryos (Her-
mann et al., 2004; Craven et al., 2005). Dihydrorhodamine is
an uncharged fluorescent ROS indicator which passively diffuses
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FIGURE 7 |Transferase dUTP nick end labeling staining of 5 dpf embryos. More fluorescent dots are observed in the tail region of Abcc6a-MO injected fish
(right) demonstrating more apoptosis compared to the tail region of the wild-type fish (left).
across membranes where it is oxidized to cationic rhodamine
123 which localizes in the mitochondria and exhibits green
fluorescence (Song et al., 2009).
ANALYSIS OF MITOCHONDRIAL MEMBRANE POTENTIALITY
Recent findings show that besides the production of ATP, mito-
chondria also contribute to several other cellular functions, includ-
ing redox homeostasis, calcium homeostasis, and cell death (Schef-
fler, 2001). Mitochondrial mutations (inherited or somatic) are
responsible for many developmental abnormalities (Zhang et al.,
2012). Mitochondrial dysfunction also plays an important role
in many mineralization diseases; i.e., in PXE and vascular calci-
fication where decreased mitochondrial membrane potentiality
(MMP) and reduced ion gradient has been reported. Measuring
MMP allows assessment of mitochondrial function and integrity
(Nicholls and Budd, 2000).
Different methods exist to measure MMP in ZF, including stain-
ing with membrane-potential-dependent dyes such as Rhodamine
123, tetramethylrhodamine ethyl ester (TMRE), fluorescent car-
bocyanine dye JC-1, or MitoTracker (Chazotte, 2010; Mitra and
Lippincott-Schwartz, 2010). MitoTracker is a commercially avail-
able fluorescent dye, which labels mitochondria within live cells.
Among available probes, MitoTracker Red is a red-fluorescent dye
widely used for labeling mitochondria in live ZF embryos/cells and
its accumulation depends upon membrane potential (Figure 8).
Live ZF embryos are incubated in the dark with 25–500 nM Mito-
Tracker Red CM-H2XRos working solution for 2 h at 28.5˚C, and
observed under a fluorescent microscope. MitoTracker can also
stain the endoplasmic reticulum if embryos/cells are exposed to a
higher MitoTracker solution for a prolonged period of time. How-
ever, high concentration and prolonged exposure can also block
mitochondrial activity, so a low concentration with short time
exposure is recommended to obtain specific staining (Ryu et al.,
2011).
CHEMICAL SCREENING AND DRUG DISCOVERY
Due to easy diffusion of chemicals through the skin, ZF allows
disease-driven drug target identification and in vivo validation,
thus representing an interesting bioassay tool for small molecule
testing and dissecting biological pathways (Pichler et al., 2003). In
a MO injection based reverse genetic approach, chemical screening
is very useful to find a chemical/drug which rescues morphant phe-
notypes (Taylor et al., 2010). Peterson et al. (2000) screened 1100
synthetic small molecules against ZF embryos arrayed in 96 well
plates to identify molecules that specifically modulated develop-
mental processes, and found that one tetrazole derivative affected
otolith development. By adding and removing the chemical, they
determined a critical stage for otolith development that occurs
between 14 and 26 h after fertilization. This demonstrates that
drug screening in ZF can provide more insights in physiological
and developmental processes.
Pichler et al. (2003) proposed two broad strategies for drug
development in ZF. First, large-scale random chemical screen-
ing against diseased or control ZF can be performed to observe
biologically interesting phenotypic changes; secondly, functional
understanding of disease pathways can allow to determine specific
target genes directly associated with the disease followed by chem-
ical screening against that gene. In combination with microarray,
ZF promise to be a cost and efficient bioassay that can simulta-
neously uncover drug candidates, estimate toxicity, primary and
secondary drug targets, and phenotypic outcomes (Pichler et al.,
2004). As many ectopic mineralization disorders are currently
still intractable, this model may prove efficient to further explore
therapeutic options.
SYSTEMS BIOLOGY APPROACHES
The multidisciplinary approaches of systems biology allow us
to quantitatively study of the fundamental principles of a bio-
logical system, aiming at better understanding the connections
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FIGURE 8 | Detection of mitochondrial membrane potentiality on
2 dpf embryos by MitoTracker Red CM-H2XRos staining. (A)
Control fish showing no fluorescent staining, and (B) staining with
500 nM MitoTracker Red CM-H2XRos for 2 h showing fluorescent
staining of mitochondria in the head region of a mitochondrial disease
model.
FIGURE 9 | Overview of MO injection and post-injection follow-up to study ectopic mineralization zebrafish models.
between gene, protein, and cellular networks. ZF is regarded as an
ideal vertebrate model for studying genotype-phenotype relation-
ships, pathway analysis, and systems biology. Deo and MacRae
(2011) described the possibility of a systems biology approach
in ZF for functional annotation of the genome, elucidation of
multicellular processes in vivo, expression profiling and genome-
wide association, phenotypic architecture, disease heterogeneity,
and drug responses. Several systems biology approaches have
already been developed to study ZF models; among them, the
comparative study of embryonic development between mor-
phants and controls can break new ground in understanding
and uncovering disease mechanisms. However, the bottleneck of
these approaches is the huge amount of data that needs to be
analyzed.
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IN TOTO IMAGING
Megason and Fraser (2007) recently described “Digital Fish
project” to upload ZF development into computer for better
understanding how genome computes the formation of an embryo
from an egg. In their project they combine confocal/2-photon
imaging with genetics, genomics, synthetic biology, and computa-
tional analysis to watch biological circuits function in vivo and use
these data in cell-based modeling. They developed “in toto imag-
ing” to track all cells in a developing tissue and record cell-based
quantitative data by using fluorescent reporters. In this imaging
process they used “segmentation marker” to track cells, captured
3D time-lapse movies on confocal and custom built 2-photon
microscope, and finally used a software package called GoFigure
to determine complete lineages and cell-based frameworks for use
in modeling.
FLIP TRAPS
Flip traps is a novel gene trap technique to generate endogenously
expressed functional fluorescent fusion protein, and they gener-
ate Cre conditional alleles. Fluorescent fusion protein is used to
non-invasively quantify expression and localization of proteins
in vivo. Flip Traps in combination with “in toto imaging” can dig-
itize expression and phenotype with single-cell resolution for use
in molecular and cellular modeling of developmental processes
(Megason and Fraser, 2007).
COMPUTATIONAL APPROACH
Morelli et al. (2012) recently described the use of computational
modeling (algorithm and simulation) to understand embryonic
development. They investigated four developmental patterning
strategies of the embryo: (1) gradients of signaling molecules
released from localized source cell population, (2) balance between
activator-inhibitor mechanism leading to formation of spatial
patterns, such as stripes and spots in a two dimensional space,
(3) synchronization of cellular oscillations controlling rhyth-
mic and sequential subdivision of body axis into segments, and
(4) mechanical deformation changing the pattern of a cellu-
lar population. It is shown that theoretical along with experi-
mental/computational data can play an important role to dis-
close mechanisms of development. Following the same approach
between control and morphant embryos will give an opportunity
to understand underlying differential mechanisms. The Prereq-
uisite for using this approach is that the level of description and
model type are matched to quantitative, precise, and accurate data.
This will beyond any doubt require a multidisciplinary team of
specialists.
IN VIVO MODELING
Genetic and genomic features, conservation of intermolecular net-
work, as well as physiologic and phenotypic features have made ZF
an important model for systems biology studies. Deo and MacRae
(2011) described homology and high-throughput phenotyping
strategies which can be used for genetic or chemical screening
on a scale compatible with in vivo validation for systems biology.
Advent and validation of MO and increasing efficiency of
transgenesis have made it possible to study hundreds of genes
with specific phenotypes. Generally, phenotypic investigation of
these approaches has been limited by phenotyping throughput.
Now, the possibility of automated, quantitative phenotypes can
lead to more comprehensive screenings. Moreover, applying a
known causal mutation background in ZF models can aid to
uncover disease mechanism. This type of analysis is also very useful
to understand genotype-phenotype correlations including pene-
trance, pleiotropy, and pathogenicity. ZF disease models combined
with known/approved libraries of drugs may enable collection
of datasets which can be highly informative not only for disease
network architecture, but also for pharmacogenetics.
CONCLUSION
Ectopic mineralization disorders feature some important med-
ical issues to be resolved because of their complex pathogenesis,
uncertainties on the mechanisms that deposit mineral in tissues
or how to remove it from the tissues, and the unavailability of
specific drugs and treatments. Until now, many experiments have
been done both on patients and mammalian model organisms
but the pathophysiological mechanisms of many ectopic miner-
alization disorders are still incompletely understood. Because of
the limitations to perform studies on human tissues – often due
to the invasive procedures needed to obtain them – and the high
cost, long breeding time and complexity to achieve knockdown
of genes in mouse models, the ZF has come to attention as an
alternative model organism. Several studies have shown that there
are many similarities in the molecular pathways and mechanisms
involved in (pathological) mineralization between ZF and mam-
malians, even if the phenotypic consequences are not identical
for obvious reasons. Using MO injection based knockdown, ZF
can be an important disease model to study mineralization dis-
orders. This is because phenotypic and molecular genetic results
can be obtained within hours, because of the possibility of close
observation in the developing transparent embryos and because
of the easy application of techniques in the post-injection period.
The concern of off-target or aspecific findings can be addressed
by applying one or more alternative knock-down approaches.
By considering aforementioned advantages, ZF can be used as
a novel model organism for ectopic mineralization disorders.
After MO-based knockdown, the described (Figure 9) valida-
tion and post-injection follow-up can be applied to gain insights
in the mechanisms and future therapeutics of mineralization
disorders.
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